Sole rearrangement but not amplification ofMYCis associated with a poor prognosis in patients with diffuse large B cell lymphoma and B cell lymphoma unclassifiable-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Sole rearrangement but not amplification ofMYCis associated with a poor prognosis in patients with diffuse large B cell lymphoma and B cell lymphoma unclassifiable

Published:2016-07-29 Issue:4 Volume:175 Page:631-640
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Landsburg Daniel J.¹,Falkiewicz Marissa K.²,Petrich Adam M.³⁴,Chu Benjamin A.⁵,Behdad Amir⁶,Li Shaoying⁷,Medeiros L. Jeffrey⁷,Cassaday Ryan D.⁸,Reddy Nishitha M.⁹,Bast Martin A.¹⁰,Vose Julie M.¹¹,Kruczek Kimberly R.¹²,Smith Scott E.¹²,Patel Priyank¹³,Hernandez-Ilizaliturri Francisco¹³,Karmali Reem¹⁴,Rajguru Saurabh¹⁵,Yang David T.¹⁶,Maly Joseph J.¹⁷,Blum Kristie A.¹⁸,Zhao Weiqiang¹⁹,Vanslambrouck Charles²⁰,Nabhan Chadi²¹

Affiliation:

1. Division of Hematology/Oncology; University of Pennsylvania; Philadelphia PA USA

2. Robert Wood Johnson Medical School; Rutgers University; New Brunswick NJ USA

3. Division of Hematology/Oncology; Northwestern University; Chicago IL USA

4. AbbVie; Chicago IL USA

5. Feinberg School of Medicine; Northwestern University; Chicago IL USA

6. Department of Pathology; Northwestern University; Chicago IL USA

7. Department of Hematopathology; MD Anderson Cancer Center; Houston TX USA

8. Seattle Cancer Care Alliance; University of Washington; Seattle WA USA

9. Division of Hematology/Oncology; Vanderbilt University; Nashville TN USA

10. Lymphoma Study Group; University of Nebraska Medical Center; Omaha NE USA

11. Division of Oncology & Hematology; University of Nebraska Medical Center; Omaha NE USA

12. Division of Hematology/Oncology; Loyola University Chicago; Chicago IL USA

13. Department of Medicine; Roswell Park Cancer Institute; Buffalo NY USA

14. Rush University Cancer Center; Rush University; Chicago IL USA

15. Division of Hematology/Oncology; University of Wisconsin; Madison WI USA

16. Department of Pathology and Laboratory Medicine; University of Wisconsin; Madison WI USA

17. Division of Hematology/Oncology; Ohio State University; Columbus OH USA

18. Division of Hematology; Ohio State University; Columbus OH USA

19. Department of Pathology; Ohio State University; Columbus OH USA

20. Department of Pathology; University of Chicago; Chicago IL USA

21. Section of Hematology/Oncology; University of Chicago; Chicago IL USA

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.14282/fullpdf

Reference31 articles.

1. Double-hit B-cell lymphomas;Aukema;Blood,2011

2. Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphoma;Aukema;Haematologica,2014

3. Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab;Barrans;Journal of Clinical Oncology,2010

4. Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of todays knowledge;Boerma;Leukemia,2009

5. Isolated MYC cytogenetic abnormalities in diffuse large B-cell lymphoma do not predict an adverse clinical outcome;Caponetti;Leukaemia & Lymphoma,2015

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A phase 1-2 trial of DA-EPOCH-R plus ixazomib for MYC-aberrant lymphoid malignancies: the DACIPHOR regimen;Blood Advances;2024-03-27

2. MYC rearrangements in HIV-associated large B-cell lymphomas: EUROMYC, a European retrospective study;Blood Advances;2024-02-16

3. The Clinicopathologic Features and Molecular Signatures of Blastoid High-Grade B Cell Lymphoma, Not Otherwise Specified;Modern Pathology;2023-12

4. TP53 mutations predict for poor outcomes in patients with newly diagnosed aggressive B-cell lymphomas in the current era;Blood Advances;2023-11-30

5. Prognostic significance of copy number gains of MYC detected by fluorescence in situ hybridization in large B-cell lymphoma;Leukemia & Lymphoma;2023-10-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3